Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy
- 30 July 1998
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 353 (2-3), 191-206
- https://doi.org/10.1016/s0014-2999(98)00410-5
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Levetiracetam (ucb LO59) affects in vitro models of epilepsy in CA3 pyramidal neurons without altering normal synaptic transmissionNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1997
- Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsyEpilepsy Research, 1995
- Kindling Increases the Sensitivity of Rats to Adverse Effects of Certain Antiepileptic DrugsEpilepsia, 1995
- Contrasting effects of adenosine A1 and A2 receptor ligands in different chemoconvulsive rodent modelsEuropean Journal of Pharmacology, 1993
- ucb L059, a novel anti-convulsant drug: pharmacological profile in animaisEuropean Journal of Pharmacology, 1992
- Tolerance to the anticonvulsant effect of benzodiazepinesTrends in Pharmacological Sciences, 1988
- Chronic benzodiazepine treatment increases the effects of the inverse agonist FG7142Neuropharmacology, 1988
- Protection against chemically induced seizures by 2-amino-7-phosphonoheptanoic acidEuropean Journal of Pharmacology, 1982
- A permanent change in brain function resulting from daily electrical stimulationExperimental Neurology, 1969
- Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mousePsychopharmacology, 1968